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Background: Acute kidney injury (AKI) is a common and serious condition usually detected some time after onset
by changes in serum creatinine (sCr). Although stent grafting to repair aortic aneurysms is associated with AKI
caused by surgical procedures or the use of contrast agents, early biomarkers for AKI have not been adequately
examined in stent graft recipients. We studied biomarkers including urinary neutrophil gelatinase-associated
lipocalin (NGAL), blood NGAL, N-acetyl-β-D-glucosaminidase (NAG), microalbumin (Alb), and liver fatty acid-binding
protein (L-FABP) as prospective early biomarkers for AKI in patients who had received stent graft repairs of aortic
aneurysms.
Methods: In addition to pre-surgical sampling, at 2 to 6 h and at 1, 3 to 4, and 5 days or later (until stable) after
surgery, urine and serum biomarkers were sampled from 47 patients who underwent stent graft repair of aortic
aneurysms.
Results: Using Acute Kidney Injury Network criteria, 6 (14%) of 42 retained patients developed AKI. NGAL corrected
with urine Cr (NGAL/Cr) values demonstrated the best predictive value for AKI (97% specificity, 83% sensitivity at a
65.1 μg/gCr cutoff). The area under the receiver-operator characteristic curve of NGAL/Cr value 2 h after surgery
was 0.9. Although NGAL/Cr, L-FABP corrected with urine Cr (L-FABP/Cr), L-FABP, NAG, and Alb corrected by urine Cr
(Alb/Cr) all reached peak values before AKI detection by sCr in AKI patients, all biomarkers reached the cutoff value
before AKI detection after adaption of cutoff value.
Conclusions: After stent graft repair of aortic aneurysm, NGAL/Cr is a potentially useful early biomarker for AKI.
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Acute kidney injury (AKI) after cardiac or other major
surgery is associated with extended intensive care and pro-
longed hospital stay, diminished quality of life, shorter
long-term survival, and other adverse effects [1]. Unfortu-
nately, for a variety of reasons, serum creatinine (sCr) is a
slow and unreliable indicator of AKI [2]. The failure of
interventional trials to attenuate AKI has been attributed,
in part, to late diagnosis. This has spurred recent interest* Correspondence: kueta@anes.med.osaka-u.ac.jp
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unless otherwise stated.in discovering and validating biomarkers that enable
earlier diagnosis of AKI [2]. Initial studies have suggested
promising candidates, including neutrophil gelatinase-
associated lipocalin (NGAL), interleukin (IL)-18, liver fatty
acid-binding protein (L-FABP), kidney injury molecule
(KIM)-1 [2], and microalbumin (Alb) [3]. Krawczeski and
colleagues [2] have reported, however, that when AKI oc-
curs after cardiopulmonary bypass (CPB), urinary NGAL
concentration rises more quickly than L-FABP, IL-18, and
KIM-1.
Thoracic or abdominal aortic aneurysm is lethal if left
untreated. Endovascular aortic repair with a stent graft is
an alternative procedure that avoids open surgery [4]. Des-
pite the risk of renal dysfunction owing to the surgicald. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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after stent graft surgery, we found few studies concerned
with using novel renal biomarkers for the early detection
of AKI [5,6]. Although Chang and colleagues [5] reported
increased blood NGAL (bNGAL) values in all patients
after stent graft insertion, they did not measure urine bio-
markers. In the other study, providing no useful evidence
of the performance of novel AKI biomarkers, AKI after
stent graft insertion occurred in only 1 of 34 patients [6].
Consequently, conjecturing that certain renal biomarkers
are capable of providing earlier indication of AKI than sCr
after stent graft surgery, we carried out experiments to test
this hypothesis. We also evaluated the predictive ability of
the tested biomarkers and how well they predicted subse-
quent long-term elevation of sCr. We wanted to find out
whether some biomarkers were capable of early detection
of AKI and subsequent long-term sCr elevation.
Methods
Patients
This study was approved by the Institutional Review Board
of Osaka University Medical School. All patients undergo-
ing endovascular stent graft repair of aortic aneurysm at
our center from December 2010 to March 2011 were pro-
spectively enrolled after obtaining written informed con-
sent from each patient. Patients with pre-existing renal
failure, indicated by sCr >3 mg/dL and those requiring
renal replacement therapy were excluded.
Study protocol
Considering the findings by Mishrav and colleagues [7],
before surgery and after at 2 to 6 h and at 1, 3 to 4, and
5 days or more (until stable), 2 mL of blood and 10 mL of
spot urine were collected from each patient. The blood
and urine samples were spun at 2,000 × g within 24 h and
the supernatant was frozen and stored at −80°C for later
analysis. Urinary NGAL was evaluated using chemilumin-
escent immunoassay (CLIA; ARCHITECT®, Abbott Diag-
nostics, Abott Park, IL, USA), bNGAL using commercially
available enzyme-linked immunosorbent assay (ELISA)
kits (BioPorto Diagnostics, Grusbakken, Denmark), and
urinary L-FABP using commercially available ELISA kits
(CIMIC Co., Tokyo, Japan). Results for urinary N-acetyl-β-
D-glucosaminidase (NAG), Alb, and creatinine were pro-
vided by a commercial lab. Values for sCr were obtained
at baseline, 2 to 6 h after surgery and routinely monitored
once a day. Besides measuring sCr and bNGAL, we tested
biomarkers from urine. Results for urinary biomarkers
such as NGAL, L-FABP, and albumin were normalized to
urine creatinine concentrations and to compensate for
possible urinary dilution or concentration, values are pre-
sented as urinary biomarker/Cr × 100.
AKI was characterized according to Acute Kidney Injury
Network (AKIN) sCr criteria: stage 1, sCr rising to morethan 0.3 mg/dL or to 50% over baseline; stage 2, increasing
by 200% to 300%; stage 3, increasing by more than 300%.
Because most patients returned to general wards after sur-
gery, we did not include urine output criteria. Basic demo-
graphic, surgery duration, and hospital-stay data were
collected. To evaluate the relationship of biomarkers and
long-term outcome of kidney injury, sCr was recorded at
1, 3, and 6 months after surgery.
Statistical analysis
Statistical analysis was performed using JMP version 9.0.3
(SAS Institute, Cary, NC, USA) and Analyse-it version
2.26 (Analyse-it Software, Leeds, West Yorkshire, UK).
Demographics, baseline measurements, and clinical out-
comes of AKI and non-AKI patients were compared, as
appropriate, using unpaired t testing, Pearson’s test, or
Kruskal-Wallis test. Univariable logistic regression was
used to assess the discriminative ability of biomarkers to
predict AKI. Receiver-operator characteristic (ROC) curves
were generated for each biomarker at 2 to 6 h after sur-
gery. Cross comparison of areas under the curves (AUC)
of each biomarker was done using methods developed by
DeLong [8].
Data were expressed as mean ± SD (standard deviation),
median (95% confidence interval) or median ±QD (quar-
tile deviation) as appropriate and P < 0.05 was considered
significant.
Results
Five of 47 enrolled patients who underwent graft stent
replacement therapy were excluded: 1 owing to incom-
plete data and 4 owing to urinary tract infection that
caused continuously elevated levels of urine NGAL [9].
AKI occurred in 6 of the retained 42 patients and was
detected 37 ± 44 h after surgery by sCr (Table 1). Five of
these six AKI patients developed stage 1 AKI and one
patient progressed to AKI stage 2. Each of the AKI
group specifically underwent thoracic endovascular aor-
tic repair (TEVAR, subtotal N = 18). None of the en-
rolled patients required dialysis or died within 30 days
after surgery.
Time-course elevation of biomarkers
As shown in Figure 1, during the sampling period, the
values for all biomarkers from non-AKI patients remained
consistently low. In AKI patients, values for each bio-
marker, except bNGAL and Alb/Cr, statistically significantly
increased at some point after surgery. Statistically signifi-
cant differences between sCr, NGAL, NGAL/Cr, L-FABP,
and L-FABP/Cr values for AKI and non-AKI patients were
first seen in samples taken at 2 to 6 h after surgery. Such
differences for Alb and NAG were not apparent until post-
operative day (POD) 3 or 4. Compared with the values, cor-
rected with urine Cr (uCr) for each other biomarker in AKI
Table 1 Demographic data and clinical outcomes
Non-AKI AKI P value
N 36 6
Operation type (TEVAR/EVAR) 18/18 6/0 0.007
Female (%) 14 0 0.33
Age (year) 70 ± 9 68 ± 13 0.65
Height (cm) 164 ± 7 169 ± 6 0.12
Weight (kg) 65 ± 11 72 ± 12 0.17
Diabetes mellitus (%) 25 16 0.64
Pre-operation sCr (mg/dL) 1.08 ± 0.27 0.95 ± 0.27 0.23
Surgery duration (min) 137 ± 53 231 ± 144 0.11
Hospital stay (day) 13.5 ± 11.8 22.5 ± 13.8 0.08
Data was expressed as mean ± SD except hospital stay (median ± quartile
deviation). TEVAR, thoracic endovascular aortic repair; EVAR, endovascular
aortic repair.
Figure 1 Urinary biomarker concentration in patients with and witho
Asterisk indicates statistically significant differences (P < 0.05) in medians be
creatinine (sCr); B, urinary neutrophil gelatinase-associated lipocalin (NGAL)
NGAL (bNGAL); E, urinary microalbumin (Alb); F, Alb corrected with urine c
liver fatty acid-binding protein (L-FABP) I, L-FABP corrected with urine crea
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elevated at subsequent measurements.
To assess if other biomarkers more quickly indicated
AKI than sCr, the difference in time taken to reach peak
value for each biomarker was compared with times to
AKI detection by sCr (Table 2). Elapsed time after sur-
gery was scaled as follows: 2 to 6 h, 4 h; more than
1 day, and POD (24-h units). NGAL/Cr, Alb/Cr, NAG,
L-FABP, and L-FABP/Cr values peaked before sCr detec-
tion of AKI, and Alb peaked at about the same time as
sCr detection.
Predictive ability of biomarkers
Figure 2 presents ROC curves derived from univariable lo-
gistic regression analysis for each biomarker value in sam-
ples taken 2 to 6 h after surgery. The ROC curve AUC for
NGAL/Cr was 0.9, statistically significantly greater than
for Alb/Cr (P = 0.04) (Table 3).ut acute kidney injury. Median and quartile deviations are shown.
tween patients with and without acute kidney injury. A, serum
; C, urinary NGAL corrected with urine creatinine (NGAL/Cr); D, blood
reatinine (Alb/Cr); G, N-acetyl-β-D-glucosaminidase (NAG) H, urinary
tinine (L-FABP/Cr).
Table 2 Time to reach maximum biomarker value,
compared with serum creatinine detection of acute
kidney injury
Biomarker Time (h)
NGAL 29 (−32, 90)
NGAL/Cr −32 (−85, 21)
bNGAL 20 (−31, 71)
Alb 0 (−55, 55)
Alb/Cr −8 (−68, 52)
NAG −7 (−61, 46)
L-FABP −15 (−40, 10)
L-FABP/Cr −29 (−79, 21)
Data was expressed as median (95% confidence interval). Minus sign indicates
that the biomarker reached the peak value earlier than serum creatinine.
NGAL, urinary neutrophil gelatinase-associated lipocalin; NGAL/Cr, urinary
NGAL corrected with urine creatinine; bNGAL, blood neutrophil gelatinase-
associated lipocalin; Alb, urinary microalbumin; Alb/Cr, urinary microalbumin
corrected with urine creatinine; NAG, N-acetyl-β-D-glucosaminidase; L-FABP,
urinary liver fatty acid-binding protein; L-FABP/Cr, urinary liver fatty acid-binding
protein corrected with urine creatinine.
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cutoff values indicating maximum sensitivity and specifi-
city (Table 3). From the tested biomarkers, NGAL/Cr per-
formed the best, with sensitivity of 0.83 and specificity of
0.97. This result is almost same as for the TEVAR-only
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Figure 2 Receiver-operator characteristic curves for biomarker prediction
gelatinase-associated lipocalin; NGAL/Cr, urinary NGAL corrected with urinary c
urinary microalbumin corrected with urinary creatinine; L-FABP/Cr, urinary liverAfter detecting the cutoff values for each biomarker,
we compared the difference in time taken to reach the
cutoff value for each biomarker with the time to AKI de-
tection by sCr (Table 5). All biomarkers reached cutoff
values before sCr detection; NGAL/Cr, Alb/Cr, and L-
FABP/Cr reached cutoff values much earlier than other
biomarkers.
Ability to predict long-term sCr value elevation
Each biomarker was evaluated taking the maximum
value or the 2 to 6 h postsurgical value. At 1, 3, and
6 months after surgery, none of the tested biomarkers
was statistically significantly associated with higher levels
of sCr than before surgery.
Discussion
This study evaluated novel biomarkers for AKI after
endovascular stent graft surgery. We found that NGAL
corrected with uCr provided the earliest and most reli-
able indication of AKI. On the other hand, these early
values did not predict longer-term sCr values.
As a promising alternative to open-surgery procedures,
endovascular aortic repair is increasingly applied for aortic
aneurysm and dissection [4]. The advantages of endovas-
cular aneurysm repair endovascular aortic repair (EVAR)
and TEVAR, including shorter operating time, less blood
loss, and shorter hospital stay, have to be weighed against









of acute kidney injury 2 to 6 h after surgery. NGAL, urinary neutrophil
reatinine; bNGAL, blood NGAL; NAG, N-acetyl-β-D-glucosaminidase; Alb/Cr,
fatty acid-binding protein corrected with urine creatinine.
Table 3 Effectiveness of early biomarker prediction of AKI at 2 to 6 h after surgery: total patient population
Biomarker AUC Cutoff Sensitivity Specificity Diagnosis concordance
NGAL 0.90 17.7 (ng/mL) 0.83 0.84 0.83
NGAL/Cr 0.90 65.1 (μg/gCr) 0.83 0.97 0.95
bNGAL 0.69 267.8 (ng/mL) 0.60 0.67 0.61
Alb 0.76 81.5 (μg/mL) 0.60 0.87 0.83
Alb/Cr 0.78 210 (mg/gCr) 0.80 0.90 0.89
NAG 0.62 6.6 (U/L) 0.66 0.57 0.59
L-FABP 0.87 25.1 (ng/mL) 0.83 0.83 0.83
L-FABP/Cr 0.86 36.7 (μg/gCr) 0.83 0.74 0.76
sCr 0.88 1.17 (mg/dL) 0.83 0.69 0.85
AUC, area under the curve; NGAL, urinary neutrophil gelatinase-associated lipocalin; NGAL/Cr, urinary NGAL corrected with urine creatinine; bNGAL, blood
neutrophil gelatinase-associated lipocalin; Alb, urinary microalbumin; Alb/Cr, urinary microalbumin corrected with urine creatinine; NAG, N-acetyl-β-D-glucosaminidase;
L-FABP, urinary liver fatty acid-binding protein; L-FABP/Cr, urinary liver fatty acid-binding protein corrected with urine creatinine; sCr, serum creatinine.
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agents [4]. In the current study, the incidence of AKI was
14% after stent graft repair surgery, which is in line with pre-
vious reports (1.5% to 34%) [4], although it must be noted
that AKI criteria vary according to study [10]. Because
sCr, the conventional marker of renal function, is affected
by several non-renal factors such as muscle mass, age, and
sex, and does not usually peak until 1 to 3 days after car-
diac surgery, alternative effective early diagnosis of AKI
would facilitate more rapid therapeutic intervention and
could help reduce the development of AKI [11].
With this end in view, several new biomarkers have been
proposed and evaluated [12]. Measured on the day of AKI
diagnosis, IL-18 and albumin values to creatinine ratio
have been associated with higher risk of AKI progression
and worse outcomes after cardiac surgery [13]. After adult
cardiac surgery, L-FABP and NAG values have been
shown to be useful indicators of AKI [14]. Meanwhile, it
has been suggested that urine NGAL concentrations,
which peak earliest during renal infection after cardiopul-
monary bypass procedures, have the highest predictiveTable 4 Effectiveness of early biomarker prediction of AKI at
Biomarker AUC Cutoff Sen
NGAL 0.91 15.2 (ng/mL) 0.8
NGAL/Cr 0.90 65.1 (μg/gCr) 0.8
bNGAL 0.70 267.8 (ng/mL) 0.6
Alb 0.72 81.5 (μg/mL) 0.6
Alb/Cr 0.72 210 (mg/gCr) 0.8
NAG 0.59 6.6 (U/L) 0.6
L-FABP 0.82 25.1 (ng/mL) 0.8
L-FABP/Cr 0.79 36.8 (μg/gCr) 0.8
sCr 0.89 1.17 (mg/dL) 0.8
TEVAR, thoracic endovascular aortic repair, AUC, area under the curve; NGAL, urinar
with urine creatinine; bNGAL, blood neutrophil gelatinase-associated lipocalin; Alb,
creatinine; NAG, N-acetyl-β-D-glucosaminidase; L-FABP, urinary liver fatty acid-bindi
urine creatinine; sCr, serum creatinine.value for AKI [2]. This early presence occurs owing to up-
regulation, just minutes after ischemia-reperfusion injury,
of NGAL by renal distal tubular cells and its secretion into
urine [15]. Corroborating Krawczeski’s findings, of the bio-
markers we tested, we also importantly found that NGAL
values at 2 to 6 h after surgery provided the best and most
reliable prediction of AKI.
Possibly related to the abundance of NGAL/MMP-9
complexes associated with human aortic aneurysms [16],
which may find their way into the bloodstream, Chang
and colleagues [5] have reported increased bNGAL values
in all patients after stent graft insertion. The extent of this
association has yet to be determined, however, because
both the ELISA kit (R&D Systems, Minneapolis, MN,
USA) used in that study and the assay kit we used are un-
able to evaluate NGAL/MMP-9 complexes. Moreover, in
medical conditions that stent graft patients are susceptible
to, such as infection or diabetes mellitus, possibly due to
the release of NGAL from cell types in organs other than
kidney, in the present study, analysis of the bNGAL data
that we acquired was unable to provide sufficiently reliable2 to 6 h after surgery: TEVAR group










y neutrophil gelatinase-associated lipocalin; NGAL/Cr, urinary NGAL corrected
urinary microalbumin; Alb/Cr, urinary microalbumin corrected with urine
ng protein; L-FABP/Cr, urinary liver fatty acid-binding protein corrected with
Table 5 Time to reach cutoff value of each biomarker,
compared with serum creatinine detection of AKI
Biomarker Time (h)
NGAL −30 (−68, 8)
NGAL/Cr −40 (−96, 16)
bNGAL −19(−71, 33)
Alb −20 (−51, −2)
Alb/Cr −40 (−96, 16)
NAG −19 (−37, 0)
L-FABP −30 (−76, 16)
L-FABP/Cr −40 (−96,16)
Data was expressed as median (95% confidence interval). Minus sign indicates
that biomarker reached the cutoff value earlier than serum creatinine. NGAL,
urinary neutrophil gelatinase-associated lipocalin; NGAL/Cr, urinary NGAL
corrected with urine creatinine; bNGAL, blood neutrophil gelatinase-associated
lipocalin; Alb, urinary microalbumin; Alb/Cr, urinary microalbumin corrected
with urine creatinine; NAG, N-acetyl-β-D-glucosaminidase; L-FABP, urinary liver
fatty acid-binding protein; L-FABP/Cr, urinary liver fatty acid-binding protein
corrected with urine Cr.
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The duration of surgery was also shorter than in the report
of Chang and colleagues. Consequently, in our samples,
there may have been less bNGAL released in response to
general systemic inflammation. In most clinical studies,
urinary NGAL has been reported to be five to ten times
higher than plasma NGAL after kidney injury and this may
consequently make urinary NGAL more suitable for faster
detection with AKI with greater specificity [11,15,16].
We were unable to find previous results for compari-
son of AKI after TEVAR and non-thoracic endovascular
aneurysm repair but since all the patients in our AKI
group underwent TEVAR, it seems likely that TEVAR
increases the risk of renal ischemia [17] and microembo-
lism [4]. There is also evidence that suprarenal stent-
graft fixation is significantly more likely to increase urine
microalbumin than infrarenal fixation [18].
Although all biomarkers reached cutoff values before
sCr AKI detection, among adapted cutoff values in our
small population, NGAL/Cr was the most reliable of the
early indicators of AKI detected.
Four patients (9%) of the 47 originally enrolled also had
to be excluded owing to urinary tract infection, because
high NGAL values associated with such infection may have
caused false positive detection of AKI [9]. Testing for a
combination of biomarkers along with NGAL may improve
the reliability of early detection of AKI in cardiovascular
surgery patients with multiple complications, including
urinary tract infection.
While AKI is commonly associated with prolonged
hospital stay, greater healthcare costs, and earlier mor-
tality [12], in the current study we found no statistically
significant difference in the length of hospital stay. This
may be because endovascular surgery is less invasive
than open surgery and because our AKI group patientsCr values returned to baseline soon after surgery. Simi-
larly, we found no association with any of our renal bio-
marker results and subsequent long-term detection of sCr
elevation after surgery. Although our conclusions may be
revised in light of the findings from further studies includ-
ing, for example, sampling of larger populations or ana-
lysis of the effects of surgical procedures on the renal
artery, after stent graft repair surgery, with the proviso that
correction with urine Cr may be necessary because NGAL
can detect AKI more quickly than earliest detection using
sCr, we advocate testing for urinary NGAL, corrected by
uCr, as an early diagnostic indicator of AKI.
Limitations
This study has some obvious limitations.
Owing to lack of human resources, we were unable to
fix specific time points for sampling and settled, for ex-
ample, for 2 to 6 h and 3 to 4 days, which yields data
that is not as precise as it could be. Our sampling-point
decisions, however, were based on the findings of Mishra
and colleagues, who reported that urinary NGAL peaks
at 4 h and plateaus 60 h after surgery: they measured
NGAL once a day after POD 1 in patients who had
undergone cardiac surgery [7].
Although we expected a 20% to 25% incidence of AKI,
the incidence was only 14%. Our smaller sample size
may have introduced greater alpha error in the statistical
analysis. Human resource limitations and experimental
time constraints, however, did not allow further patient
enrollment.
Meanwhile, for one patient in our AKI group, although
clinical signs of renal failure such as low urine output and
sCr elevation became apparent soon after surgery, bNGAL,
NAG, and L-FABP were the only biomarker values that
exceeded the relevant cutoff values. In some studies, NGAL
has not performed well, resulting in false negative results
[2,19]. Consequently, the usefulness of NGAL as a bio-
marker for diagnosing AKI has yet to be established, and
further study is obviously required to obtain more data for
mortality, dialysis requirement, ICU stay, length of hospital
stay, and other relevant outcomes.
Conclusions
The results of this first study to evaluate the effective-
ness of novel biomarkers for AKI after stent graft repair
surgery have shown that NGAL corrected by uCr can
provide early detection and prediction of AKI.
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